Morning Movers

SAN CARLOS, Calif., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (NASDAQ: APGN) a clinical-stage company focused on developing innovative...

Alvotech (NASDAQ First North: ALVO) tilkynnti í dag um samskipti við Matvæla- og lyfjaeftirlit Bandaríkjanna (FDA) sem varða úttekt á...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...

-Treatment with VCN-01 in combination with durvalumab demonstrated an acceptable safety profile and encouraging biological activity-ROCKVILLE, Md., Sept. 05, 2022...